How fast can you get your Aortic Stenosis patient thru the system.? Time matters in TAVI candidates with decompensated aortic stenosis #AHAJournals Michael McKenna Thomas Treibel Guy Lloyd Sanjeev Bhattacharyya Michael Mullen ahajrnls.org/3ZRLsXS

I’ve attended many opening ceremonies but this time I had goosebumps..the message resonated “EQUITY” accessibility, reproducibility, standardization “INNOVATION” we drive science & we push boundaries.. #WeAreNYValves 🗽 Cardiovascular Research Foundation Juan F. Granada Marty Leon David J. Cohen, MD, MSc RTHahnMD

The exploration in the management of tricuspid valve disease continues. Treatment of large anatomy tricuspid valve with the LuX-Valve Plus. Early results of Trinity Trial presented Cardiovascular Research Foundation #NYValves2025

Will treatment of triscupid regurgitation result in RV remodeling? Early feasibility data of the VDyne system from the VISTA Studies Cardiovascular Research Foundation #NYValves2025

“Turning implants into smart devices”. The Microtech Pressure Sensor. Maybe the future is that every heart failure patient with have a sensor. Could this be the end of the RHC? Michael Savage Cardiovascular Research Foundation #NYValves2025

Alternative access #TAVR via carotid artery. Live case presentation at Cardiovascular Research Foundation #NYValves2025 I find this approach fascinating with clinical data in a large registry to be presented tommorrow Done in less than 30 minutes.

What a kickoff to #NYValves2025! 🚀 From cutting-edge science to hands-on sessions, today was packed with innovation, education, and amazing connections. Here’s a glimpse of the excitement from Day 1! 🔥🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch Juan F. Granada

TRILUMINATE Pivotal RCT:Cross-over Patients. A natural history study of the trajectory of patients with severe TR. Crossover patients fared worse than those who did not cross-over. Is there any surprises here? Cardiovascular Research Foundation #NYValves2025

Echocardiography findings from TRISCEND II. TTVR eliminates TR at one-year with improvement in venous congestion and cardiac output. Cardiovascular Research Foundation #NYValves2025

How TR grade translate into quality of life outcomes. Need to achieve at least mild or no TR to have the most beneficial effect. Results from the Tri-QOL Study presented Cardiovascular Research Foundation #NYValves2025

Prognostication of extra-cardiac involvement on outcomes after TEER. Can staging be a valuable risk stratification tool? “ Looking for the sweet spot?” Cardiovascular Research Foundation #NYValves2025

Leaving Cardiovascular Research Foundation #NYValves2025. Google maps: take me to the nearest subway. You are here 🤷🏻‍♂️. I forgot about Subways Michael Savage Julia Grapsa MD, PhD Ritu Thamman MD Mamas A. Mamas Dr Anastasia Mihailidou FAHA FCSANZ FESC

Ditto! Thanks for the opportunity to be in attendance. Cardiovascular Research Foundation #NYValves2025

#TAVR via transcarotid approach is promising. 5yr outcomes from our TC-TAVR cohort IUCPQ-ULaval (proctoring centre with years of TC-TAVR experience)~50% of moderate-to-high risk pts event-free, low stroke rate, <1% BVF Juan H del Portillo Jean-Michel Paradis David L. Fischman Cardiovascular Research Foundation #NYValves2025

Congratulations Dr. DeMaria Structural Heart Cardiovascular Research Foundation for a job well done!

Most PCI in US Now Done By Radial Access. It’s about time! 👍 Sunil V. Rao David J. Cohen, MD, MSc Robert W. Yeh Eric Secemsky MD MSc Mamas A. Mamas Ian C Gilchrist Sr Sripal Bangalore MIЯVΛƬ #IC Ayman Magd Hany Ragy Sandeep Nathan, MD, MSc Salman Arain SABOURETCardiologist Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 David L. Fischman tctmd.com/news/most-pcis…

"Thank you for your service" Dr. David Auth, a professor of bioengineering at the UW, and Michael Slota developed the #Rotablator in the 1980s as an alternative to traditional angioplasty and bypass surgery for treating blocked arteries #CompCourse2025 Cardiovascular Research Foundation

Midterm outcomes in a Patient Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Sustained valve competence, beneficial cardiac remodeling and improved QOL Matthew Gillespie Arash Salavitabar, MD #cardiotwitter #AHAJournals ahajrnls.org/4nTarV5

💡Get insights from #TCT2025 Program Director Dr. Gary Mintz on how this year’s meeting is advancing the field! Don’t miss critical learning in coronary care featuring cutting-edge imaging, physiology, and CT-guided PCI planning. Take a first look at the program now. More

Nice comprehensive review EuroIntervention Justifies the need for more imaging. #cardiotwitter